KWS Saat SE (0F1N)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 68.10 |
|---|---|
| 52-week range | 62.20 – 80.30 |
| Return, 1 month / 3 months | −13.2% / −6.6% |
| Return, 1 year / 3 years | +1.4% / +38.4% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 24.0% |
| Worst drawdown (1 year) | -17.0% |
| Average daily value traded | 0.09M EUR |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
KWS Saat is a plant breeding and seed company based in Germany. It develops and markets seeds for crops such as sugar beet, maize, cereals and oilseed rape, along with other agricultural crops. Its customers are farmers and agricultural businesses that buy seed for commercial crop production. The company also carries out plant research and breeding work to develop new crop varieties suited to different growing conditions and markets around the world.
KWS Saat SE trades under the code 0F1N on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
KWS Saat SE (0F1N) trades on the London Exchange in UK. It last closed at EUR 68.10 on 21 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,945 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.4% and over the last three months it fell 6.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.8% | ||
| From 52-week high | -14.4% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.6% | ||
| 6-month return | -8.3% | ||
| 12-month return, skipping the last month | 16.9% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.0% | ||
| Liquidity | 29 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M EUR | ||
| Zero-volume days | 11.7% | ||
| Income | 50 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.4% |
|---|---|
| 1 month | −13.2% |
| 3 months | −6.6% |
| 6 months | −8.3% |
| 1 year | +1.4% |
| 3 years | +38.4% |
| 5 years | −0.6% |
Signals
| 50-day / 200-day average | 73.00 / 71.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Dec 2025 | EUR 1.2500 |
| 6 Dec 2024 | EUR 1.0000 |
| 14 Dec 2023 | EUR 0.9000 |
| 7 Dec 2022 | EUR 0.8000 |
| 3 Dec 2021 | EUR 0.8000 |
| 17 Dec 2020 | EUR 0.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.